Human hallucinogen research: guidelines for safety (Q24600704)

Journal of Psychopharmacology

Europe PubMed Central

title

Human hallucinogen research: guidelines for safety (English)

0 references

author name string

Mw Johnson

series ordinal

1

0 references

Wa Richards

series ordinal

2

0 references

Rr Griffiths

series ordinal

3

0 references

language of work or name

English

0 references

publication date

August 2008

0 references

published in

0 references

volume

22

0 references

page(s)

603-20

0 references

issue

6

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Effects of psilocybin on time perception and temporal control of behaviour in humans

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

The adverse effects of hallucinogens from intramural perspective.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Altered states of consciousness and short-term psychological after-effects induced by the first time ritual use of ayahuasca in an urban context in Brazil

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Comparison of acute lethal toxicity of commonly abused psychoactive substances

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose?effect study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

The pharmacology of psilocybin

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Experimental Psychiatry. V — Psilocybine, a New Psychotogenic Drug

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Some observations on psilocybin, a new hallucinogen, in volunteer subjects

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

REACTIONS TO PSILOCYBIN ADMINISTERED IN A SUPPORTIVE ENVIRONMENT.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Use of d-lysergic acid diethylamide in the treatment of alcoholism.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Hallucinogen persisting perception disorder: what do we know after 50 years?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Flashback and Hallucinogen Persisting Perception Disorder: clinical aspects and pharmacological treatment approach.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

A systems model of altered consciousness: integrating natural and drug-induced psychoses

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Do hallucinogens cause residual neuropsychological toxicity?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Treatment of alcoholism using psychedelic drugs: a review of the program of research

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Methodological issues of human experimental research with hallucinogens

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Human psychopharmacology of N,N-dimethyltryptamine

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Adverse consequences of lysergic acid diethylamide

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Toward a comparative overview of dependence potential and acute toxicity of psychoactive substances used nonmedically

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE

27 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

27 September 2017

https://api.crossref.org/works/10.1177%2F0269881108093587

The Effects of LSD on Body Sway Suggestibility in a Group of Hospital Patients

21 January 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

27 September 2017

https://api.crossref.org/works/10.1177%2F0269881108093587

A clinical study of LSD treatment in alcoholism

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

27 September 2017

LSD and Genetic Damage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

A review of LSD treatment in alcoholism

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Psychedelic drugs and mystical experience.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Does LSD induce chromosomal damage and malformations? A review of the literature

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Attenuation of anticipation: A therapeutic use of lysergic acid diethylamide

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Relative abuse liability of lorazepam and diazepam: an evaluation in 'recreational' drug users

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Human hallucinogenic drug research in the United States: a present-day case history and review of the process

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Voluntary Drug Self-Administration by Nonhumans; A Review

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

LSD before Leary. Sidney Cohen's critique of 1950s psychedelic drug research

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

LSD revisited. A ten-year follow-up of medical LSD use.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

The use of psychedelic agents with autistic schizophrenic children

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

New Records of Mushroom Stones from Guatemala

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

A Controlled Comparison of Lysergic Acid Diethylamide (LSD) and Dextroamphetamine in Alcoholics

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

In vivo and in vitro chromosomal damage induced by LSD-25.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

LSD-assisted psychotherapy in patients with terminal cancer.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

A mescaline associated fatality.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Chronic Administration of Serotonergic Antidepressants Attenuates the Subjective Effects of LSD in Humans

30 May 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093587

Alterations in responses to LSD in humans associated with chronic administration of tricyclic antidepressants, monoamine oxidase inhibitors or lithium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093587

Psilocybin impairs high-level but not low-level motion perception

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093587

Hallucinogens and redemption

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093587

New blocking agent against the development of LSD-25 psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093587

Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093587

Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093587

Effects of the hallucinogen psilocybin on covert orienting of visual attention in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093587

Hallucinogens at the turn of the century: an introduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093587

Psychological and cognitive effects of long-term peyote use among Native Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093587

Comparison of the reactions induced by psilocybin and LSD-25 in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093587

PSYCHOPATHOLOGY OF LSD INTOXICATION; STUDY OF EXPERIMENTAL PSYCHOSIS INDUCED BY LSD-25: DESCRIPTION OF LSD SYMPTOMS IN NORMAL ORIENTAL SUBJECTS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093587

REACTIONS TO PSILOCYBJN ADMINISTERED IN A SUPPORTIVE ENVIRONMENT

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093587

Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093587

Hallucinogens of Plant Origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093587

Can psychedelics have a role in psychiatry once again?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093587

The effects of psychotomimetic drugs on primary suggestibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093587

Effect of chronic antidepressant treatment and subsequent withdrawal on [3H]-5-hydroxytryptamine and [3H]-spiperone binding in rat frontal cortex and serotonin receptor mediated behaviour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093587

Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093587

Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093587

Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093587

The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093587

Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093587

5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093587

Cross tolerance between mescaline and LSD-25 with a comparison of the mescaline and LSD reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093587

Lysergic acid diethylamide: side effects and complications.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Psychoses produced by administration of drugs.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans.

28 November 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

28 November 2018

https://api.crossref.org/works/10.1177%2F0269881108093587

7 January 2021

inferred from DOI database lookup

Ethical and practical issues involved in behavioral pharmacology research that administers drugs of abuse to human volunteers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056407

Comparison of psilocin with psilocybin, mescaline and LSD-25

28 November 2018

1 reference

12 December 2020

Chromosomal damage in human leukocytes induced by lysergic acid diethylamide

1 reference

12 December 2020

Drug-Induced Schizophrenia

1 reference

12 December 2020

LSD and chromosomes. A controlled experiment

1 reference

12 December 2020

Potentiation of LSD-induced stimulus control by fluoxetine in the rat

1 reference

12 December 2020

Complications associated with lysergic acid diethylamide (LSD-25)

1 reference

12 December 2020

Chromosome Damage Not Found in Leukocytes of Children Treated with LSD-25

1 reference

12 December 2020

Psychotogenic drugs as models for schizophrenia

1 reference

12 December 2020

LSD in the supportive care of the terminally ill cancer patient

1 reference

12 December 2020

Chromosomal abnormalities in leukocytes from LSD-25 users

1 reference

12 December 2020

Clinical, biochemical and psychologic effects of psilocybin

1 reference

12 December 2020

Suicide during an LSD reaction

1 reference

12 December 2020

[Research on psiloybin, a psychotropic substance from Psilocybe mexicana.]

1 reference

12 December 2020

STUDY OF LYSERGIC ACID DIETHYLAMIDE AS AN ANALGESIC AGENT

1 reference

12 December 2020

Residential psychedelic (LSD) therapy for the narcotic addict. A controlled study

1 reference

12 December 2020

A controlled study of lysergide in the treatment of alcoholism. 1. The effects on drinking behavior

1 reference

12 December 2020

Human hallucinogen interactions with drugs affecting serotonergic neurotransmission

1 reference

12 December 2020

Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man

1 reference

12 December 2020

Reviving research into psychedelic drugs

1 reference

12 December 2020

Reviving the study of hallucinogens

1 reference

12 December 2020

Mescaline, lysergic acid diethylamide and psilocybin comparison of clinical syndromes, effects on color perception and biochemical measures

1 reference

12 December 2020

LSD in the Treatment of Alcoholics*

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093587

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1177/0269881108093587

1 reference

812228

812228

1 reference

1 reference

1 reference